Silver Book Fact

The initiation of insulin therapy in the management of type 2 diabetes involves an approximate 10% increase in total health care expenditures initially, although this is offset by the consistent and substantial 40% decrease in subsequent total health care expenditures 9 months following insulin initiation.

Rosenblum M, Kane M. Analysis of Cost and Utilization of Health Care Services Before and After Initiation of Insulin Therapy in Patients with Type 2 Diabetes Mellitus. J Managed Care Pharm. 2003; 9(4): 309-16. http://www.amcp.org/data/jmcp/Research-309-316.pdf

Reference

Title
Analysis of Cost and Utilization of Health Care Services Before and After Initiation of Insulin Therapy in Patients with Type 2 Diabetes Mellitus
Publication
J Managed Care Pharm
Publication Date
2003
Authors
Rosenblum M, Kane M
Volume & Issue
Volume 9, Issue 4
Pages
309-16
URL
Read Full Resource

Categories

  • Innovative Medical Research
  • Economic Value

Related Facts

  • Anti-VEGF Letter Improvement
    An anti-VEGF therapy for DME improved vision by more than 15 letters in approximately 36-51% of participants in a trial.  
  • Following the current path, diabetes cases will increase by 52.9% between 2003 and 2023. If an alternative path is taken, there will be 13.3% (2.8 million) fewer diabetes cases.  
  • DR Treatment Savings in the US
    Every year, the U.S. saves an estimated $1.6 billion by treating DR.  
  • In a community-based pharmaceutical care services program for 194 participants in 2001, mean A1c decreased at follow-ups, with more than 50% of patients demonstrating improvements at each interval (each year…  
  • For every 10 mmHg reduction in systolic blood pressure, the risk of diabetic complications is reduced by 12%.